Report overview
This report contains market size and forecasts of Biopharmaceutical Contract Manufacturing(BCMO) in Global, including the following market information:
Global Biopharmaceutical Contract Manufacturing(BCMO) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Biopharmaceutical Contract Manufacturing(BCMO) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Mammalian Based Manufacturing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biopharmaceutical Contract Manufacturing(BCMO) include Lonza Group Ltd, Boehringher Ingelheim, Sandoz, Fujifilm Diosynth Biotechnology, Rentschler Biotechnologie, Celonic GmbH, BIOMEVA GmbH and ProBioGen AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biopharmaceutical Contract Manufacturing(BCMO) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biopharmaceutical Contract Manufacturing(BCMO) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biopharmaceutical Contract Manufacturing(BCMO) Market Segment Percentages, by Type, 2021 (%)
Mammalian Based Manufacturing
Microbial Based Manufacturing
Other
Global Biopharmaceutical Contract Manufacturing(BCMO) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biopharmaceutical Contract Manufacturing(BCMO) Market Segment Percentages, by Application, 2021 (%)
Bio-Pharmaceutical Companies
Pharmaceutical Companies
Drug Discovery Companies
Other
Global Biopharmaceutical Contract Manufacturing(BCMO) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biopharmaceutical Contract Manufacturing(BCMO) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biopharmaceutical Contract Manufacturing(BCMO) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Biopharmaceutical Contract Manufacturing(BCMO) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lonza Group Ltd
Boehringher Ingelheim
Sandoz
Fujifilm Diosynth Biotechnology
Rentschler Biotechnologie
Celonic GmbH
BIOMEVA GmbH
ProBioGen AG
